What is Needham's price target for VRCA?

Needham's latest stated price target for Verrica Pharmaceuticals Inc. (VRCA) is $10, from its action on Jul 25, 2023.

What is Needham's rating on VRCA?

Needham rates VRCA Buy, a bullish rating, as of Jul 25, 2023.

When did Needham last change its view on VRCA?

On Jul 25, 2023, Needham upgrades to Buy from Hold, price target $10.

Needham VRCA price target and rating history

Verrica Pharmaceuticals Inc. (VRCA) · Health Care

Needham rates Verrica Pharmaceuticals Inc. (VRCA) Buy with a $10 price target, as of its latest action on Jul 25, 2023. It has published 3 rating actions on VRCA since September 2021, including 1 upgrade and 0 downgrades.

Current rating: Buy
Price target: $10
Median target, all firms: Too few
Actions on VRCA: 3

Needham price target on VRCA

Needham price target on VRCA, each point a stated target, September 2021 to July 2023.

Every Needham rating on VRCA

Jul 25, 2023
UpgradeNeedham upgrades to Buy from Hold, price target $10
Mar 3, 2022
ReiterateNeedham cuts its price target to $18 from $20, keeps Buy
Sep 21, 2021
ReiterateNeedham cuts its price target to $20 from $22, keeps Buy

How other firms rate VRCA

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Lake Street	Buy	$9	Aug 27, 2026
H.C. Wainwright	Buy	$12	May 26, 2026

Questions about Needham and VRCA

What is Needham's price target for VRCA?: Needham's latest stated price target for Verrica Pharmaceuticals Inc. (VRCA) is $10, from its action on Jul 25, 2023.
What is Needham's rating on VRCA?: Needham rates VRCA Buy, a bullish rating, as of Jul 25, 2023.
When did Needham last change its view on VRCA?: On Jul 25, 2023, Needham upgrades to Buy from Hold, price target $10.

More VRCA rating histories

All Needham ratings VRCA news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.